ReviewJGH open : an open access journal of gastroenterology and hepatology2018

A review of vedolizumab and ustekinumab for the treatment of inflammatory bowel diseases.

Hang Hock Shim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.